Q4 Report 2020 - invitation to conference call and audiocast

Rhea-AI Summary

IRRAS will host a conference call and online presentation on February 16, 2021, at 16:00 CET to discuss its Q4 2020 interim report, which will be released earlier that day at 08:00 CET. The event will be accessible via dial-in numbers: Sweden: +46 8 56 64 27 03 and International: +44 33 33 00 92 71. The presentation will also be webcast at this link. CEO Kleanthis G. Xanthopoulos, along with other executives, will speak during the event.

Positive

• Anticipated release of Q4 2020 interim report may provide insights into financial performance.
• Scheduled conference call suggests transparency and engagement with investors.

Negative

• None.

STOCKHOLM, Feb. 9, 2021 /PRNewswire/ -- On Tuesday February 16, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q4 2020 interim report (which will have been published earlier on the 16^th at 08.00 CET). The presentation will be held in English.

The dial-in numbers for the conference call are:

Sweden: +46 8 56 64 27 03

Rest of the world: +44 33 33 00 92 71

The presentation will be webcast and can be accessed from the following web address:

https://tv.streamfabriken.com/irras-q4-2020 

Speakers: CEO Kleanthis G. Xanthopoulos, Ph.D., President and CCO Will Martin and CFO Sabina Berlin

About IRRAS

IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in the United States and select European countries as well as an international network of distribution partners.

IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA.  For more information, please visit www.irras.com.

IRRAS AB (publ) is listed on Nasdaq Stockholm (ticker: IRRAS).

For more information, please contact:

USA

Kleanthis G. Xanthopoulos, Ph.D.
CEO
ir@irras.com 

Europa

Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com 

The information was released for public disclosure, through the agency of the contact person above, on February 9, 2020 at 08:00 (CET).

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/irras/r/q4-report-2020---invitation-to-conference-call-and-audiocast,c3282290

 

View original content:http://www.prnewswire.com/news-releases/q4-report-2020--invitation-to-conference-call-and-audiocast-301224562.html

SOURCE IRRAS

FAQ

What is the date and time of the IRRAS Q4 2020 interim report presentation?

The presentation is scheduled for February 16, 2021, at 16:00 CET.

How can I access the Q4 2020 interim report from IRRAS?

The report will be published at 08:00 CET on February 16, 2021, and can be accessed during the conference call.

What is the purpose of the IRRAS conference call on February 16, 2021?

The conference call will discuss the Q4 2020 interim report and provide insights into the company's performance.

Who will be speaking during the IRRAS conference call?

Speakers include CEO Kleanthis G. Xanthopoulos, President and CCO Will Martin, and CFO Sabina Berlin.

What are the dial-in numbers for the IRRAS conference call?

The numbers are: Sweden: +46 8 56 64 27 03, International: +44 33 33 00 92 71.